The PathLAKE centre of excellence will play a leading role in the development, validation and implementation of AI in cellular pathology. The centre data lake will be an invaluable resource for AI researchers and UK based SMEs, enabling the development of cutting-edge AI algorithms for cellular pathology as well as capturing and revealing trends and patterns in the pathology image data for better understanding of disease and improved provision of patient healthcare.
Professor Nasir Rajpoot, Head of the Tissue Image Analytics laboratory
Department of Computer Science, University of Warwick

Increasing access to a vast amount of image information and applying analysis of the kind that PathLAKE will deliver will move diagnostic evaluation to new depths. These technologies will be key to our understanding and utilisation of clinical information. The knowledge PathLAKE will unlock, both in the short and long-term future, will completely change cancer care in the NHS while embedding a world-leading life-sciences and technology sector in our health system
Dr David Snead Consultant
University Hospitals Coventry and Warwickshire NHS Trust

Pathology is central to ensuring accurate diagnosis for patients with diseases such as cancer, and in determining the precise course of action. However, our aging population, with rapidly rising sample requirements and increasing case complexity, are placing ongoing pressures on a workforce, which is itself aging. This creates challenges to ensuring early diagnosis and precision therapies and requires urgent attention, so we are delighted the UK government recognises the potential that digitisation and AI could bring to pathology. We are excited to play a part in helping the UK to take a leading role in the development and delivery of these new technologies that can improve patient outcomes and re-invigorate the workforce. With PathLAKE our aim is realise large scale AI-driven cancer analysis, we see this as a significant step toward realising the true potential of personalised medicine and supporting the NHS
Peter Hamilton, Head of Research and Life Sciences Lead
Philips Digital and Computational Pathology